𝔖 Bobbio Scriptorium
✦   LIBER   ✦

Vaccination of prostatectomized prostate cancer patients in biochemical relapse, with autologous dendritic cells pulsed with recombinant human PSA

✍ Scribed by Benoît Barrou; Gérard Benoît; Mahmoud Ouldkaci; Olivier Cussenot; Margarita Salcedo; Sudhanshu Agrawal; Séverine Massicard; Nadège Bercovici; MatsL. Ericson; Nicolas Thiounn

Publisher
Springer-Verlag
Year
2004
Tongue
English
Weight
224 KB
Volume
53
Category
Article
ISSN
0340-7004

No coin nor oath required. For personal study only.

📜 SIMILAR VOLUMES

Follow-up evaluation of prostate cancer
Follow-up evaluation of prostate cancer patients infused with autologous dendritic cells pulsed with PSMA peptides
✍ Tjoa, B.A.; Erickson, S.J.; Bowes, V.A.; Ragde, H.; Kenny, G.M.; Cobb, O.E.; Ire 📂 Article 📅 1997 🏛 John Wiley and Sons 🌐 English ⚖ 211 KB 👁 2 views

## BACKGROUND. We recently conducted a phase I clinical trial administering autologous dendritic cells pulsed with prostate-specific membrane antigen (PSMA) peptides to advanced prostate cancer patients. Participants were divided into 5 groups receiving 4 or 5 infusions of peptides alone (PSM-P1 o

Vaccination of advanced prostate cancer
Vaccination of advanced prostate cancer patients with PSCA and PSA peptide-loaded dendritic cells induces DTH responses that correlate with superior overall survival
✍ Anna-K. Thomas-Kaskel; Robert Zeiser; Rosa Jochim; Christian Robbel; Wolfgang Sc 📂 Article 📅 2006 🏛 John Wiley and Sons 🌐 French ⚖ 257 KB

## Abstract Prostate stem cell antigen (PSCA) and prostate‐specific antigen (PSA) are overexpressed in most prostate cancers. PSCA‐ and PSA‐derived, HLA‐A2 binding peptides are specific targets for T‐cell responses __in vitro.__ A phase I/II trial was performed to demonstrate feasibility, safety an

Infusion of dendritic cells pulsed with
Infusion of dendritic cells pulsed with HLA-A2-specific prostate-specific membrane antigen peptides: A phase II prostate cancer vaccine trial involving patients with hormone-refractory metastatic disease
✍ Murphy, G.P.; Tjoa, B.A.; Simmons, S.J.; Jarisch, J.; Bowes, V.A.; Ragde, H.; Ro 📂 Article 📅 1999 🏛 John Wiley and Sons 🌐 English ⚖ 225 KB 👁 2 views

## Background: A phase ii trial was conducted to assess the efficacy of infusions of dendritic cells (dc) and two hla-a2-specific psma peptides (psm-p1 and -p2). this report describes thirty three subjects with hormone-refractory metastatic prostate cancer without prior vaccine therapy history who